Cannabinoid Receptor Ligands Available from Tocris
Agonists
CB 2 selective antagonist/inverse agonist
Agonist for putative abnormal-CBD receptor
Selection of 3 CB 1 receptor ligands (Cat. Nos. 1319, 1121 and 1117)
Potent, highly selective CB 1 agonist
Selection of 5 endogenous cannabinoids (Cat. Nos. 1339, 1298, 1568,
Potent, selective CB 1 agonist
1411 and 1569)
Potent, selective CB 1 agonist (in water-soluble emulsion)
CB 2 -selective antagonist/inverse agonist
Endogenous CB receptor agonist
Selective CB 1 receptor antagonist/inverse agonist
Endogenous CB receptor agonist (in water-soluble emulsion)
Silent antagonist for putative abnormal-CBD receptor
Endogenous cannabinoid agonist
CB 1 silent antagonist
Potent CB 1 and TRPV1 agonist/anandamide transport inhibitor
Endogenous CB 1 partial agonist/antagonist. Also CB 2 agonist
CB 1 /CB 2 receptor partial agonist
CB 2 antagonist/CB 1 partial inverse agonist. Enantiomer of Cat. No.
1038
Selection of 3 CB 1 receptor ligands (Cat. Nos. 1319, 1121 and 1117)
Other
1462
Selection of 5 cannabinoid receptor agonists (Cat. Nos. 1339, 1298,
Inhibits anandamide hydrolysis
0949, 0966 and 1038)
1116
Anandamide transport inhibitor
Potent CB 1 and CB 2 agonist
Anandamide transport inhibitor (in water-soluble emulsion)
Endogenous CB 1 agonist
Inhibits pain in vivo
Selection of 5 endogenous cannabinoids (Cat. Nos. 1339, 1298, 1568,
1411 and 1569)
Novel endocannabinoid. Suppresses pain in vivo
Selective, high affinity CB 2 receptor partial agonist
Potent, selective CB 2 ligand
Highly potent cannabinoid agonist
Natural cannabinoid; weak CB 1 antagonist and AMT inhibitor.
Anticonvulsive in vivo
Selective CB 2 agonist
Antibody recognising CB 2 receptors
Potent, selective CB 2 agonist
Blocking peptide for Cat. No. 2231
Potent, selective CB 2 agonist (in water-soluble emulsion)
Metabolically stable anandamide transport inhibitor
High affinity, selective CB 2 agonist
Novel, potent anandamide uptake inhibitor. Inhibits FAAH
Highly selective CB 2 agonist
Potent, irreversible anandamide amidase inhibitor
CB 1 agonist
Inverse agonist at a non-CB 1 , non-TRPV1 site. Active in vivo
Potent and selective CB 1 agonist
Anandamide analogue, anorexic agent
Potent and selective CB 1 agonist (in water-soluble emulsion)
Potent inhibitor of anandamide uptake
Endogenous CB 1 agonist. Also vanilloid agonist and inhibitor of FAAH
and AMT
Agonist for putative CB 2 -like receptor. FAAH and PAA substrate
2206 2-Palmitoylglycerol
Endogenous agonist for CB 1
Endogenous lipid; enhances activity of 2-AG
CB 1 receptor agonist
Inhibitor of FAAH
Agonist for putative CB 2 -like receptor. FAAH and PAA substrate
Collection of cannabinoid receptor and related compounds
Endogenous CB 2 agonist. Also CB 1 partial agonist/antagonist
Water-soluble emulsion; negative control for Cat. Nos. 1017, 1685,
1686, 1781, 1782 and 1783
Highly potent cannabinoid agonist
Antagonists
Potent anandamide transport inhibitor
1117
Potent, selective CB 1 antagonist/inverse agonist
Potent, selective anandamide transport inhibitor
1115
Potent, selective CB 1 antagonist/inverse agonist
Potent, selective anandamide transport inhibitor (in water-soluble
emulsion)
Please note, the product names used in this review are assigned according to the nomenclature employed by Tocris in its catalogue and website.
Tocris Reviews No. 27
©2006 Tocris Cookson
UK:
US:
Phone: + 44 (0)117 916 3333
Phone: 800-421-3701
Fax: + 44 (0)117 916 3344
Fax: 800-483-1993
customerservice@tocris.co.uk
customerservice@tocrisusa.com
Tocris House, Hung Road,
16144 Westwoods Business Park,
Bristol, BS11 9XJ, UK
Ellisville, Missouri 63021, USA